Inventor · disambiguated record
Yaolin Wang
Also filed as: WANG YAOLIN
25 granted patents·27 pending applications·63 citations·filing 2001–2025
93Inventor score
Files withINVENTISBIO CO LTD15SCHERING CORP8WUHAN TIANMA MICRO ELECTRONICS CO LTD6INVENTISBIO LLC5MERCK SHARP & DOHME4
Top patents by PatentIndex Score
52 records- 0190US7884107B2Substituted piperidines that increase P53 activity and the uses thereofMERCK·Filed 2007·Granted Feb 8, 2011·32 cites·36 claims
- 0289US10980807B2Inhibitor of indoleamine-2,3-dioxygenase (IDO)INVENTISBIO LLC·Filed 2017·Granted Apr 20, 2021·5 cites·11 claims
- 0389US10647724B2Selective estrogen receptor degraders and uses thereofINVENTISBIO INC·Filed 2017·Granted May 12, 2020·5 cites·28 claims
- 0488US11699373B2Display panel and display device with reduced charge accumulation in semiconductor layerWUHAN TIANMA MICRO ELECTRONICS CO LTD·Filed 2021·Granted Jul 11, 2023·2 cites·15 claims
- 0588US11374084B2Organic light emitting display panel and display deviceWUHAN TIANMA MICRO ELECTRONICS CO LTD·Filed 2019·Granted Jun 28, 2022·4 cites·19 claims
- 0683US7811562B2Biomarkers for pre-selection of patients for anti-IGF1R therapySCHERING CORP·Filed 2005·Granted Oct 12, 2010·7 cites·16 claims
- 0782US10913797B2Anti-PD-1 antibodies and therapeutic uses thereofLYVGEN BIOPHARMA HOLDINGS LTD·Filed 2016·Granted Feb 9, 2021·3 cites·23 claims
- 0880US12187736B2Selective estrogen receptor degraders and uses thereofINVENTISBIO LLC·Filed 2023·Granted Jan 7, 2025·0 cites·18 claims
- 0979US11014936B2Selective estrogen receptor degraders and uses thereofINVENTISBIO INC·Filed 2019·Granted May 25, 2021·1 cites·18 claims
- 1076US11969425B2Inhibitor of indoleamine-2,3-dioxygenase (IDO)INVENTISBIO LLC·Filed 2023·Granted Apr 30, 2024·0 cites·24 claims
- 1171US12391677B2Thyroid hormone receptor agonistsINVENTISBIO CO LTD·Filed 2019·Granted Aug 19, 2025·0 cites·10 claims
- 1270US12173010B2Heterocyclic compounds, preparation methods therefor, and methods of uses thereofINVENTISBIO CO LTD·Filed 2023·Granted Dec 24, 2024·0 cites·19 claims
- 1370US12094384B2Display panel and display device with reduced charge accumulation in semiconductor layerWUHAN TIANMA MICRO ELECTRONICS CO LTD·Filed 2023·Granted Sep 17, 2024·0 cites·20 claims
- 1470US9540377B22,6,7,8 substituted purines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Jan 10, 2017·2 cites·15 claims
- 1569US2021253592A1Selective estrogen receptor degraders and uses thereofINVENTISBIO LLC·Filed 2021·Application pending·0 cites
- 1669US2025340542A1Thyroid hormone receptor agonistsINVENTISBIO CO LTD·Filed 2025·Application pending·0 cites
- 1766US8034907B2Polynucleotides encoding soluble, stable forms of human double minute 2 polypeptidesSCHERING CORP·Filed 2009·Granted Oct 11, 2011·0 cites·7 claims
- 1865US8859776B2Substituted piperidines that increase p53 activity and the uses thereofBOGEN STEPHANE L·Filed 2010·Granted Oct 14, 2014·2 cites·44 claims
- 1965US2022054486A1Inhibitor of indoleamine-2,3-dioxygenase (ido)INVENTISBIO LLC·Filed 2021·Application pending·0 cites
- 2063US11847960B2Display panel, method for driving the same, and display apparatusWUHAN TIANMA MICRO ELECTRONICS CO LTD·Filed 2022·Granted Dec 19, 2023·0 cites·19 claims
- 2163US7705127B1HDM2 PolypeptidesSCHERING CORP·Filed 2008·Granted Apr 27, 2010·0 cites·8 claims
- 2261US12110289B2Heterocyclic compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2021·Granted Oct 8, 2024·0 cites·17 claims
- 2361US11900876B2Display panel, method for driving the same, and display apparatusWUHAN TIANMA MICRO ELECTRONICS CO LTD·Filed 2022·Granted Feb 13, 2024·0 cites·25 claims
- 2460US2025223301A1Kinase inhibitors, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2023·Application pending·0 cites
- 2560US2025263394A1Compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2023·Application pending·0 cites
- 2659US2024189313A1Solid dispersionsINVENTISBIO CO LTD·Filed 2022·Application pending·0 cites
- 2758US11691981B2Heterocyclic compounds, preparation methods therefor, and methods of uses thereofINVENTISBIO CO LTD·Filed 2020·Granted Jul 4, 2023·0 cites·21 claims
- 2858US7632920B2Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereofSCHERING CORP·Filed 2004·Granted Dec 15, 2009·0 cites·10 claims
- 2957US2024343727A1Pyridazinone or pyridinone compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2022·Application pending·0 cites
- 3057US2015093398A1Methods and Compositions for Treating or Preventing CancerMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 3157US2024211069A1Display panel and display deviceWUHAN TIANMA MICRO ELECTRONICS CO LTD·Filed 2024·Application pending·0 cites
- 3256US2025195475A1Cdk2 inhibitor and preparation method and use thereofINVENTISBIO CO LTD·Filed 2022·Application pending·0 cites
- 3356US2008004286A1Method of Using Substituted Piperidines that Increase P53 ActivitySCHERING CORP·Filed 2007·Application pending·0 cites
- 3455US2025215014A1Kinase inhibitors, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2022·Application pending·0 cites
- 3555US2023263782A1Oral formulations and uses thereofINVENTISBIO CO LTD·Filed 2021·Application pending·0 cites
- 3654US2023234017A1Plasma conversion reactor of c02 with c1 to c4 hydrocarbon to c1 to c5 oxygenate and method thereofUNIV LIVERPOOL·Filed 2021·Application pending·0 cites
- 3752US7888474B2HDM2 polypeptidesSCHERING CORP·Filed 2010·Granted Feb 15, 2011·0 cites·8 claims
- 3852US2023357233A1Heteroaryl compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2021·Application pending·0 cites
- 3951US2023242544A1Quinazoline compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2021·Application pending·0 cites
- 4051US2006233810A1Methods and compositions for treating or preventing cancerWANG YAOLIN·Filed 2006·Application pending·0 cites
- 4150US2011091524A1Biomarkers for sensitivity to anti-igf1r therapyWANG YAN·Filed 2008·Application pending·0 cites
- 4250US2014336222A1SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOFMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 4349US2011104256A1Methods for treating or preventing colorectal cancerWANG YAOLIN·Filed 2009·Application pending·0 cites
- 4449US2003109683A1Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapyBAYLOR COLLEGE MEDICINE·Filed 2002·Application pending·0 cites
- 4549US2002182698A1Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapyBAYLOR COLLEGE MEDICINE·Filed 2002·Application pending·0 cites
- 4648US12427146B2C-terminal SRC kinase inhibitorsINVENTISBIO CO LTD·Filed 2019·Granted Sep 30, 2025·0 cites·38 claims
- 4748US2011129456A1Sequential Administration of Chemotherapeutic Agents for Treatment of CancerWANG YAOLIN·Filed 2009·Application pending·0 cites
- 4847US2010087499A1Pharmaceutical compositions and methods of using temozolomide and multi-targeted kinase inhibitorsSCHERING CORP·Filed 2008·Application pending·0 cites
- 4947US2002147327A1Modified steroid hormones for gene therapy and methods for their useFiled 2001·Application pending·0 cites
- 5044US2011262525A1Methods of treatmentSCHERING CORP·Filed 2007·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yaolin Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →